Alpine Associates Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Alpine Associates Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-787,500	Closed	-$171M	–	62
2021 Q1	$171M	Buy	+787,500	New	+$148M	4.63%	7

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $983M AUM 34.23% 1-Year Est. Return

Alpine Associates Management's GWPH Position: Q2 2021 in Review

Alpine Associates Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 787,500 shares — an estimated $171M sold.

Alpine Associates Management first reported a position in GWPH in Q1 2021 and held it in 1 quarter. The position peaked at $171M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Alpine Associates Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Alpine Associates Management sold 787,500 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $171M.
Alpine Associates Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2021 and held it in 1 quarter.
Alpine Associates Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $171M in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Alpine Associates Management's 13F filing for Q2 2021, filed 11 Aug 2021.